Search Within

Eugene J Pietzak

Formats
  1. Meeting Abstract (55)
  2. Journal Article (47)
  3. Review (6)
  4. Editorial (5)
  5. Correspondence (2)
  6. Book Section (1)
  7. Guidelines (1)
Groups
  1. Surgery (117)
  2. Urology (117)
  3. Department of Medicine (88)
  4. Solid Tumor Oncology Division (87)
  5. Genitourinary Oncology Service (86)
  6. Department of Pathology and Laboratory Medicine (75)

More Groups

People
  1. Bernard Bochner (75)
  2. Hikmat Al-Ahmadie (72)
  3. David Solit (68)
  4. Gopakumar Iyer (66)
  5. Dean Bajorin (51)
  6. Jonathan Rosenberg (50)

More People

Years
  1. 2025 (10)
  2. 2024 (20)
  3. 2023 (14)
  4. 2022 (18)
  5. 2021 (16)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Urologic Oncology: Seminars and Original Investigations (11)
  3. European Urology (8)
  4. Journal of Urology (8)
  5. Clinical Cancer Research (6)
  6. Laboratory Investigation (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (37)
  2. Elsevier Science, Inc. (19)
  3. Elsevier Inc. (15)
  4. Nature Publishing Group (8)
  5. American Association for Cancer Research (7)
  6. Nature Research (5)

More Publishers

Results (117)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
    Journal Article

    Warrick, J. I.; Hu, W.; Yamashita, H.; Walter, V.; Shuman, L.; Craig, J. M.; Gellert, L. L.; Castro, M. A. A.; Robertson, A. G.; Kuo, F.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Targeted therapies in advanced and metastatic urothelial carcinoma
    Review

    Katims, A. B.; Reisz, P. A.; Nogueira, L.; Truong, H.; Lenis, A. T.; Pietzak, E. J.; Kim, K.; Coleman, J. A.
    Cancers (2022)

    Fulltext@MSK | Save
  • Long-term outcomes of local and metastatic small cell carcinoma of the urinary bladder and genomic analysis of patients treated with neoadjuvant chemotherapy
    Journal Article

    Teo, M. Y.; Guercio, B. J.; Arora, A.; Hao, X.; Regazzi, A. M.; Donahue, T.; Herr, H. W.; Goh, A. C.; Cha, E. K.; Pietzak, E.; more...
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Contemporary staging for muscle-invasive bladder cancer: Accuracy and limitations
    Review

    Hensley, P. J.; Panebianco, V.; Pietzak, E.; Kutikov, A.; Vikram, R.; Galsky, M. D.; Shariat, S. F.; Roupret, M.; Kamat, A. M.
    European Urology Oncology (2022)

    Fulltext@MSK | Save
  • Feasibility of a geriatric comanagement (GERICO) pilot program for patients 75 and older undergoing radical cystectomy
    Journal Article

    Letica-Kriegel, A. S.; Tin, A. L.; Nash, G. M.; Benfante, N. E.; McNeil, N.; Vickers, A. J.; Bochner, B.; Donat, S. M.; Goh, A.; Dalbagni, G.; more...
    European Journal of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Association of biochemically verified post-diagnosis smoking and nonmuscle-invasive bladder cancer recurrence risk
    Journal Article

    Furberg, H.; Petruzella, S.; Whiting, K.; Stein, E.; Orlow, I.; Kenney, J.; Corrales-Guerrero, S.; Benfante, N.; Cha, E. K.; Donahue, T. F.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Yip, W.; Coleman, J.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Incidence and clinical outcomes of HER2-altered bladder cancer (BC) patients (pts)
    Meeting Abstract

    Lattanzi, M.; Niederhausern, A.; Zheng, J.; Bahadur, N.; Nichols, C.; Barton, L.; Gandhi, F.; Chan, K.; Insinga, A.; Philip, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Defining innate immune training potential as a predictor of Bacillus Calmette-Guerin immunotherapy response in nonmuscle-invasive bladder cancer
    Meeting Abstract

    Jiang, S.; Redelman-Sidi, G.; Pietzak, E. J.; Bochner, B. H.; Glickman, M. S.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma
    Meeting Abstract

    Chu, C. E.; De Jesus Escano, M.; Yip, W.; Jiang, S.; Iyer, G.; Al-Ahmadie, H. A.; Goh, A. C.; Dalbagni, G.; Bochner, B. H.; Solit, D. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save